FEMARA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug FEMARA contains one active pharmaceutical ingredient (API):

1	Letrozole UNII 7LKK855W8I - LETROZOLE
	Letrozole is a non-steroidal aromatase inhibitor. It inhibits the aromatase enzyme by competitively binding to the haem of the aromatase cytochrome P450, resulting in a reduction of oestrogen biosynthesis in all tissues where present.
	Read more about Letrozole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FEMARA Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02BG04	Letrozole	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8245Y
BR	Câmara de Regulação do Mercado de Medicamentos	526506301112216
CA	Health Products and Food Branch	02231384
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00980760, 01287819, 01605248, 02129229, 05388109, 07314606, 07614923, 07614946, 09233763, 09711872, 09923947
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	21.644-1-11-04
EE	Ravimiamet	1034334, 1642340, 1642351, 1642362, 1642373, 1730775, 1730786, 1730797, 1730809, 1730810
ES	Centro de información online de medicamentos de la AEMPS	303848-10-2001, 61628
FR	Base de données publique des médicaments	64492112, 64721664, 64722435, 67359220, 68432511
GB	Medicines & Healthcare Products Regulatory Agency	240327, 368018, 381335
HK	Department of Health Drug Office	42537
HR	Agencija za lijekove i medicinske proizvode	HR-H-020668711
IE	Health Products Regulatory Authority	24571, 24572, 24701
IL	מִשְׂרַד הַבְּרִיאוּת	3637
IT	Agenzia del Farmaco	033242013, 044537025, 047270020
JP	医薬品医療機器総合機構	4291015F1026
LT	Valstybinė vaistų kontrolės tarnyba	1003012, 1073026, 1073027, 1073028, 1073029
MT	Medicines Authority	MA1249/02301
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	521M98
NG	Registered Drug Product Database	A4-3436
Switch country to Nigeria in order to find specific presentations of FEMARA
NL	Z-Index G-Standaard, PRK	47724
NZ	Medicines and Medical Devices Safety Authority	6846
SG	Health Sciences Authority	09915P
TN	Direction de la Pharmacie et du Médicament	10283061H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504090253
US	FDA, National Drug Code	0078-0249